Cargando…
MicroRNA-206 prevents hepatosteatosis and hyperglycemia by facilitating insulin signaling and impairing lipogenesis
BACKGROUND & AIMS: The paradox of selective hepatic insulin resistance, wherein the insulin-resistant liver fails to suppress glucose production but continues to produce lipids, has been central to the pathophysiology of hepatosteatosis and hyperglycemia. Our study was designed to investigate th...
Autores principales: | Wu, Heng, Zhang, Tianpeng, Pan, Fei, Steer, Clifford J., Li, Zhuoyu, Chen, Xin, Song, Guisheng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5568011/ https://www.ncbi.nlm.nih.gov/pubmed/28025059 http://dx.doi.org/10.1016/j.jhep.2016.12.016 |
Ejemplares similares
-
LXRα Promotes Hepatosteatosis in Part Through Activation of MicroRNA‐378 Transcription and Inhibition of Ppargc1β Expression
por: Zhang, Tianpeng, et al.
Publicado: (2019) -
MicroRNA-206 promotes the recruitment of CD8(+) T cells by driving M1 polarisation of Kupffer cells
por: Liu, Ningning, et al.
Publicado: (2022) -
MicroRNA-378a-3p prevents initiation and growth of colorectal cancer by fine tuning polyamine synthesis
por: Liu, Ningning, et al.
Publicado: (2022) -
Celecoxib attenuates hepatosteatosis by impairing de novo lipogenesis via Akt‐dependent lipogenic pathway
por: Zhang, Cong, et al.
Publicado: (2022) -
Circulating microRNAs Are Associated With Metabolic Markers in Adolescents With Hepatosteatosis
por: Lin, Haixia, et al.
Publicado: (2022)